Capsaicin consumption, Helicobacter pylori CagA status and IL1B-31C>T genotypes: A host and environment interaction in gastric cancer

Food and Chemical Toxicology

Volumn 50, Issue 6, 2012, Pages 2118-2122

  López Carrillo, Lizbeth ^a   Camargo, M Constanza ^b   Schneider, Barbara G ^b   Sicinschi, Liviu A ^b,d   Hernández Ramírez, Raúl U ^a   Correa, Pelayo ^b   Cebrian, Mariano E ^c  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d Holmes Regional Medical Center   (United States)

Author keywords

Capsaicin; Chili pepper; Gastric cancer; Helicobacter pylori CagA+; Interleukin 1 beta polymorphism

Indexed keywords

CAGA PROTEIN; CAPSAICIN; DNA; INTERLEUKIN 1BETA;

ADULT; ALLELE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CANCER RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HELICOBACTER PYLORI; HUMAN; IL1B GENE; MAJOR CLINICAL STUDY; MALE; MEXICO; PEPPER; POLYMERASE CHAIN REACTION; PYROSEQUENCING; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES, BACTERIAL; CAPSAICIN; DIET; DNA; FEMALE; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-1BETA; LOGISTIC MODELS; MALE; MEXICO; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK; STOMACH NEOPLASMS;

CAPSICUM FRUTESCENS; HELICOBACTER PYLORI;

EID: 84860126032     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.02.043     Document Type: Article

References (50)

1. al Qarawi A.A., Adam S.E. Effects of red chilli (Capsicum frutescens L.) on rats. Vet. Hum. Toxicol. 1999, 41:293-295.
2. Camargo M.C., Mera R., Correa P., Peek R.M., Fontham E.T., Goodman K.J., Piazuelo M.B., Sicinschi L., Zabaleta J., Schneider B.G. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1674-1687.
3. Camorlinga-Ponce M., Torres J., Perez-Perez G., Leal-Herrera Y., Gonzalez-Ortiz B., Madrazo d.l.G., Gomez A., Munoz O. Validation of a serologic test for the diagnosis of Helicobacter pylori infection and the immune response to urease and CagA in children. Am. J. Gastroenterol. 1998, 93:1264-1270.
4. Diaz Barriga A.S., Madrigal-Bujaidar E., Calderon M.E., Ramirez H.L., Diaz Garcia B.D. Genotoxic effects produced by capsaicin in mouse during subchronic treatment. Mutat. Res. 1995, 345:105-109.
5. El Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni J.F., Rabkin C.S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
6. Ericson A., Nur E.M., Petersson F., Kechagias S. The effects of capsaicin on gastrin secretion in isolated human antral glands: before and after ingestion of red chilli. Dig. Dis. Sci. 2009, 54:491-498.
7. Eslick G.D. Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence. World J. Gastroenterol. 2006, 12:2991-2999.
8. Forman D., Webb P., Parsonnet J. H. pylori and gastric cancer. Lancet 1994, 343:243-244.
9. Gajalakshmi C.K., Shanta V. Lifestyle and risk of stomach cancer: a hospital-based case-control study. Int. J. Epidemiol. 1996, 25:1146-1153.
10. Garza-Gonzalez E., Bosques-Padilla F.J., El Omar E., Hold G., Tijerina-Menchaca R., Maldonado-Garza H.J., Perez-Perez G.I. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int. J. Cancer 2005, 114:237-241.
11. Goiriena de Gandarias F.J., Santidrian M.I., Barranquero A.M. Etiopathogenic study of digestive cancer in Viscaya, with special emphasis on the role of diet and alcohol and tobacco use. Rev. Sanid. Hig. Publica (Madr.) 1988, 62:1411-1430.
12. Gonzalez C.A., Sala N., Capella G. Genetic susceptibility and gastric cancer risk. Int. J. Cancer 2002, 100:249-260.
13. Hatakeyama M. Helicobacter pylori CagA-a bacterial intruder conspiring gastric carcinogenesis. Int. J. Cancer 2006, 119:1217-1223.
14. Holzer P., Pabst M.A., Lippe I.T. Intragastric capsaicin protects against aspirin-induced lesion formation and bleeding in the rat gastric mucosa. Gastroenterology 1989, 96:1425-1433.
15. Huang J.Q., Zheng G.F., Sumanac K., Irvine E.J., Hunt R.H. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003, 125:1636-1644.
16. Hwang I.R., Kodama T., Kikuchi S., Sakai K., Peterson L.E., Graham D.Y., Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002, 123:1793-1803.
17. IARC, 1994. Schistosomes, Liver Flukes and Helicobacter pylori International Agency of Cancer Research, Lyon, France.
18. Imatake K., Matsui T., Moriyama M. The effect and mechanism of action of capsaicin on gastric acid output. J. Gastroenterol. 2009, 44:396-404.
19. Johnson W. Final report on the safety assessment of Capsicum annuum extract, Capsicum annuum fruit extract, Capsicum annuum resin, Capsicum annuum fruit powder, Capsicum frutescens fruit, Capsicum frutescens fruit extract, Capsicum frutescens resin, and capsaicin. Int. J. Toxicol. 2007, 26(Suppl. 1):3-106.
20. Jones N.L., Shabib S., Sherman P.M. Capsaicin as an inhibitor of the growth of the gastric pathogen Helicobacter pylori. FEMS Microbiol. Lett. 1997, 146:223-227.
21. Kamangar F., Cheng C., Abnet C.C., Rabkin C.S. Interleukin-1B polymorphisms and gastric cancer risk-a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1920-1928.
22. Kumar S., Kumar A., Dixit V.K. Evidences showing association of interleukin-1B polymorphisms with increased risk of gastric cancer in an Indian population. Biochem. Biophys. Res. Commun. 2009, 387:456-460.
23. Lacasana-Navarro M., Galvan-Portillo M., Chen J., Lopez-Cervantes M., Lopez-Carrillo L. Methylenetetrahydrofolate reductase 677C>T polymorphism and gastric cancer susceptibility in Mexico. Eur. J. Cancer 2006, 42:528-533.
24. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand. 1965, 64:31-49.
25. Lee I.O., Lee K.H., Pyo J.H., Kim J.H., Choi Y.J., Lee Y.C. Anti-inflammatory effect of capsaicin in Helicobacter pylori-infected gastric epithelial cells. Helicobacter 2007, 12:510-517.
26. Lee J.K., Park B.J., Yoo K.Y., Ahn Y.O. Dietary factors and stomach cancer: a case-control study in Korea. Int. J. Epidemiol. 1995, 24:33-41.
27. Lee K.A., Park J.H., Sohn T.S., Kim S., Rhee J.C., Kim J.W. Interaction of polymorphisms in the interleukin 1B-31 and general transcription factor 2A1 genes on the susceptibility to gastric cancer. Cytokine 2007, 38:96-100.
28. Li C., Xia H.H., Xie W., Hu Z., Ye M., Li J., Cheng H., Zhang X., Xia B. Association between interleukin-1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population. J. Gastroenterol. Hepatol. 2007, 22:234-239.
29. Lochhead P., El Omar E.M. Helicobacter pylori infection and gastric cancer. Best. Pract. Res. Clin. Gastroenterol. 2007, 21:281-297.
30. Lopez-Carrillo L., Fernandez-Ortega M.C., Costa-Dias R., Franco-Marina J., Alejandre-Badillo T. Beliefs about chili pepper consumption and health in Mexico City. Salud Publica Mex. 1995, 37:339-343.
31. Lopez-Carrillo L., Hernandez A.M., Dubrow R. Chili pepper consumption and gastric cancer in Mexico: a case-control study. Am. J. Epidemiol. 1994, 139:263-271.
32. Lopez-Carrillo L., Lopez-Cervantes M., Robles-Diaz G., Ramirez-Espitia A., Mohar-Betancourt A., Meneses-Garcia A., Lopez-Vidal Y., Blair A. Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico. Int. J. Cancer 2003, 106:277-282.
33. Marques S., Oliveira N.G., Chaveca T., Rueff J. Micronuclei and sister chromatid exchanges induced by capsaicin in human lymphocytes. Mutat. Res. 2002, 517:39-46.
34. Mathew A., Gangadharan P., Varghese C., Nair M.K. Diet and stomach cancer: a case-control study in South India. Eur. J. Cancer Prev. 2000, 9:89-97.
35. Mozsik G., Debreceni A., Abdel-Salam O.M., Szabo I., Figler M., Ludany A., Juricskay I., Szolcsanyi J. Small doses of capsaicin given intragastrically inhibit gastric basal acid secretion in healthy human subjects. J. Physiol. Paris 1999, 93:433-436.
36. Pociot F., Molvig J., Wogensen L., Worsaae H., Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Invest. 1992, 22:396-402.
37. Rad R., Prinz C., Neu B., Neuhofer M., Zeitner M., Voland P., Becker I., Schepp W., Gerhard M. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J. Infect. Dis. 2003, 188:272-281.
38. SIAP, 2012. Cierre de la producción agrícola por cultivo, 1994, Agricultura: Producción anualizada. Servicio de Información Agroalimentaria y Pesquera. SAGARPA, Mexico, D.F. Available from: http://www.siap.gob.mx/index.php?option=com_wrapper&view=wrapper&Itemid=350.
39. Sicinschi L.A., Lopez-Carrillo L., Camargo M.C., Correa P., Sierra R.A., Henry R.R., Chen J., Zabaleta J., Piazuelo M.B., Schneider B.G. Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes. Int. J. Cancer 2006, 118:649-657.
40. Sipetic S., Tomic-Kundakovic S., Vlajinac H., Jankovic S., Marinkovic J., Maksimovic J. Diet and gastric cancer. Vojnosanit. Pregl. 2003, 60:697-705.
41. Srinivasan M.R., Sambaiah K., Satyanarayna M.N., Rao M.V.L. Influence of red pepper and capsaicin on growth, blood constituents, and nitrogen balance in rats. Nutr. Rep. Int. 1980, 21:455-467.
42. Stewart B.W., Kleihues P. World Cancer Report 2003, IARC Press Lyon, France.
43. Torres J., Perez-Perez G.I., Leal-Herrera Y., Munoz O. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico. Int. J. Cancer. 1998, 78:298-300.
44. Tovar-Guzman V., Hernandez-Giron C., Barquera S., Rodriguez-Salgado N., Lopez-Carrillo L. Epidemiologic panorama of stomach cancer mortality in Mexico. Arch. Med. Res. 2001, 32:312-317.
45. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R.J. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001, 345:784-789.
46. Vilaichone R.K., Mahachai V., Tumwasorn S., Wu J.Y., Graham D.Y., Yamaoka Y. Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pylori cag A genotype. Scand. J. Gastroenterol. 2005, 40:530-539.
47. Vincenzi B., Patti G., Galluzzo S., Pantano F., Venditti O., Santini D., Ruzzo A., Schiavon G., Caraglia M., Marra M., Graziano F., Tonini G. Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis. Oncol. Rep. 2008, 20:1213-1220.
48. Wang P., Xia H.H., Zhang J.Y., Dai L.P., Xu X.Q., Wang K.J. Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int. J. Cancer 2007, 120:552-562.
49. World Cancer Research Fund/American Institute for Cancer Research, 2007. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. AICR, Washington, DC.
50. Yeoh K.G., Kang J.Y., Yap I., Guan R., Tan C.C., Wee A., Teng C.H. Chili protects against aspirin-induced gastroduodenal mucosal injury in humans. Dig. Dis. Sci. 1995, 40:580-583.